Front. Bioeng. Biotechnol.

Frontiers in Bioengineering and Biotechnology

Front. Bioeng. Biotechnol.

2296-4185

Frontiers Media S.A.

1478191

10.3389/fbioe.2024.1478191

Bioengineering and Biotechnology

Retraction

Retraction: Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy

Frontiers Editorial Office

10.3389/fbioe.2024.1478191

Frontiers Editorial Office *

Approved by: Gianni Ciofani, Italian Institute of Technology (IIT), Italy

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

21 08 2024

2024

1478191

09 08 2024 16 08 2024

2024

Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

A Retraction of the Original Research Article Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy by Shahidi M, Abazari O, Dayati P, Bakhshi A, Zavarreza J and Modarresi MH (2022). Front. Bioeng. Biotechnol. 10:949704. doi: 10.3389/fbioe.2022.949704

section-at-acceptance

Nanobiotechnology

The journal retracts the 5 August 2022 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures and the validity of the data in the article.

Following provision of raw data by the authors, the Chief Editor concluded that the article’s conclusions and assertions were not sufficiently supported by the findings from the material provided; therefore, the article has been retracted. The authors did not agree to this retraction.